BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29254294)

  • 1. Autophagy-related gene expression in colorectal cancer patients.
    Bednarczyk M; Muc-Wierzgoń M; Waniczek D; Fatyga E; Klakla K; Mazurek U; Wierzgoń J
    J Biol Regul Homeost Agents; 2017; 31(4):923-927. PubMed ID: 29254294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression Profile of Genes Associated with the Proteins Degradation Pathways in Colorectal adenocarcinoma.
    Martyna B; Małgorzata MW; Nikola Z; Beniamin G; Urszula M; Grażyna J
    Curr Pharm Biotechnol; 2019; 20(7):551-561. PubMed ID: 31096896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor-1alpha modulates the down-regulation of the homeodomain protein CDX2 in colorectal cancer.
    Zheng J; Sun X; Wang W; Lu S
    Oncol Rep; 2010 Jul; 24(1):97-104. PubMed ID: 20514449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional expression of HGF and its receptor in human colorectal cancer.
    Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K
    Digestion; 2000; 61(4):237-46. PubMed ID: 10878450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers.
    Kitamura S; Kondo S; Shinomura Y; Kanayama S; Miyazaki Y; Kiyohara T; Hiraoka S; Matsuzawa Y
    Br J Cancer; 2000 Sep; 83(5):668-73. PubMed ID: 10944610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical analysis of differential gene expression in colorectal cancer using CLEAR-test.
    Mazurek U; Owczarek A; Nowakowska-Zajdel E; Wierzgon J; Grochowska-Niedworok E; Kokot T; Muc-Wierzgon M
    J Biol Regul Homeost Agents; 2011; 25(2):279-83. PubMed ID: 21880217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BAX gene as a candidate for negative autophagy-related genes regulator on mRNA levels in colorectal cancer.
    Gil J; Ramsey D; Szmida E; Leszczynski P; Pawlowski P; Bebenek M; Sasiadek MM
    Med Oncol; 2017 Feb; 34(2):16. PubMed ID: 28035578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MACC1 is related to colorectal cancer initiation and early-stage invasive growth.
    Ren B; Zakharov V; Yang Q; McMahon L; Yu J; Cao W
    Am J Clin Pathol; 2013 Nov; 140(5):701-7. PubMed ID: 24124150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription of Autophagy Associated Gene Expression as Possible Predictors of a Colorectal Cancer Prognosis.
    Bednarczyk M; Muc-Wierzgoń M; Dzięgielewska-Gęsiak S; Fatyga E; Waniczek D
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-Regulated Expression of LAMP2 and Autophagy Activity during Neuroendocrine Differentiation of Prostate Cancer LNCaP Cells.
    Morell C; Bort A; Vara-Ciruelos D; Ramos-Torres Á; Altamirano-Dimas M; Díaz-Laviada I; Rodríguez-Henche N
    PLoS One; 2016; 11(9):e0162977. PubMed ID: 27627761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas.
    Violette S; Festor E; Pandrea-Vasile I; Mitchell V; Adida C; Dussaulx E; Lacorte JM; Chambaz J; Lacasa M; Lesuffleur T
    Int J Cancer; 2003 Jan; 103(2):185-93. PubMed ID: 12455032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MET amplification, expression, and exon 14 mutations in colorectal adenocarcinoma.
    Zhang M; Li G; Sun X; Ni S; Tan C; Xu M; Huang D; Ren F; Li D; Wei P; Du X
    Hum Pathol; 2018 Jul; 77():108-115. PubMed ID: 29641976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
    Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
    Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
    Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential biomarkers for the early diagnosis of colorectal adenocarcinoma - transcriptomic analysis of four clinical stages.
    Janikowska G; Janikowski T; Pyka-Pająk A; Mazurek U; Janikowski M; Gonciarz M; Lorenc Z
    Cancer Biomark; 2018; 22(1):89-99. PubMed ID: 29562499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The profile of melatonin receptors gene expression and genes associated with their activity in colorectal cancer: a preliminary report.
    Ziółko E; Kokot T; Skubis A; Sikora B; Szota-Czyż J; Kruszniewska-Rajs C; Wierzgoń J; Mazurek U; Grochowska-Niedworok E; Muc-Wierzgoń M
    J Biol Regul Homeost Agents; 2015; 29(4):823-8. PubMed ID: 26753642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas.
    Furlan D; Sahnane N; Carnevali I; Cerutti R; Bertoni F; Kwee I; Uccella S; Bertolini V; Chiaravalli AM; Capella C
    Hum Pathol; 2008 Oct; 39(10):1483-94. PubMed ID: 18619649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of p53/BAX in primary colorectal carcinoma: low BAX protein expression is a negative prognostic factor in UICC stage III tumors.
    Schelwies K; Sturm I; Grabowski P; Scherübl H; Schindler I; Hermann S; Stein H; Buhr HJ; Riecken EO; Zeitz M; Dörken B; Daniel PT
    Int J Cancer; 2002 Jun; 99(4):589-96. PubMed ID: 11992551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.